Metcalfe P D, Cain M P, Kaefer M, Gilley D A, Meldrum K K, Misseri R, King S J, Casale A J, Rink R C
Department of Pediatric Urology, James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, 702 North Barnhill Drive, Indianapolis, IN 46202, USA.
J Urol. 2006 Oct;176(4 Pt 2):1801-5; discussion 1805. doi: 10.1016/j.juro.2006.03.126.
Bladder augmentation has revolutionized the care of children with a neuropathic bladder but it remains a major surgical procedure. However, the need for subsequent bladder surgery has not been well defined in a large series with long-term followup.
We retrospectively reviewed the records of the first 500 bladder augmentations performed from 1978 to 2003 at our institution. Charts were reviewed for complications requiring additional surgery, including malignancy, bladder perforation, repeat augmentation, bowel obstruction and bladder calculi. Mean and median followup was 13.3 years.
Complications occurred in 169 patients (34%) resulting in a total of 254 surgeries. The cumulative risk of further surgery at the bladder level was 0.04 operations per patient per year of augmentation. Three patients (0.6%) had transitional cell carcinoma, of whom all presented with metastatic disease and died. Bladder perforation occurred in 43 patients (8.6%) with a total of 53 events. Of the patients 16 (3.2%) required laparotomy for bowel obstruction and 47 (9.4%) required repeat augmentation. Bladder stones were treated in 75 patients (15%), who required a total of 125 surgeries.
Bladder augmentation provides immeasurable improvements in quality of life but it requires lifelong dedication from the patient, family and health care providers. While the requirements for additional surgery are not trivial, 66% of our patients have not required any further surgery in the augmented bladder.
膀胱扩大术彻底改变了神经源性膀胱患儿的治疗方式,但它仍是一项重大的外科手术。然而,在一个进行长期随访的大样本系列研究中,后续膀胱手术的必要性尚未得到明确界定。
我们回顾性分析了1978年至2003年在我院进行的前500例膀胱扩大术的记录。查阅病历以了解需要额外手术的并发症,包括恶性肿瘤、膀胱穿孔、再次扩大术、肠梗阻和膀胱结石。平均随访时间和中位随访时间为13.3年。
169例患者(34%)出现并发症,共进行了254次手术。膀胱水平进一步手术的累积风险为每位患者每年扩大术0.04次手术。3例患者(0.6%)发生移行细胞癌,所有患者均出现转移性疾病并死亡。43例患者(8.6%)发生膀胱穿孔,共53次事件。16例患者(3.2%)因肠梗阻需要剖腹手术,47例患者(9.4%)需要再次扩大术。75例患者(15%)接受了膀胱结石治疗,共进行了125次手术。
膀胱扩大术在生活质量方面带来了不可估量的改善,但它需要患者、家庭和医疗服务提供者的终身投入。虽然额外手术的需求并非微不足道,但我们66%的患者在扩大后的膀胱中不需要任何进一步的手术。